Allan Ronald

Author PubWeight™ 98.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012 27.84
2 The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005 4.48
3 Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010 4.23
4 Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007 3.78
5 Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One 2009 3.66
6 Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One 2011 3.27
7 Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis 2005 3.00
8 Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med 2013 2.44
9 The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003 2.39
10 HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav 2006 1.83
11 Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry 2010 1.73
12 Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav 2011 1.66
13 HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009 1.64
14 Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics. Nature 2006 1.48
15 Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS 2010 1.37
16 Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 2007 1.35
17 Resurrecting the triple threat: academic social responsibility in the context of global health research. Clin Infect Dis 2009 1.29
18 The academic alliance for AIDS care and prevention in Africa. Acad Med 2008 1.27
19 Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda. J Acquir Immune Defic Syndr 2006 1.25
20 The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci 2008 1.25
21 Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics. Nature 2006 1.13
22 Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One 2009 1.11
23 Meningitis caused by Streptococcus suis serotype 14, North America. Emerg Infect Dis 2009 1.11
24 Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. Afr Health Sci 2004 1.10
25 The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. Int J Infect Dis 2007 1.10
26 Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity. J Int Assoc Physicians AIDS Care (Chic) 2008 1.07
27 HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy. J Acquir Immune Defic Syndr 2016 1.02
28 Advances in clinical education: a model for infectious disease training for mid-level practitioners in Uganda. Int J Infect Dis 2012 1.02
29 Measuring the outcomes of a comprehensive HIV care course: pilot test at the Infectious Diseases Institute, Kampala, Uganda. J Acquir Immune Defic Syndr 2006 1.01
30 An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr 2014 0.98
31 Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. AIDS 2014 0.97
32 Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. AIDS 2014 0.96
33 Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009. Antimicrob Agents Chemother 2011 0.96
34 The liver in HIV in Africa. Antivir Ther 2005 0.94
35 Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans. J Infect Dis 2013 0.91
36 Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology 2012 0.91
37 Treatment of HIV/AIDS: do the dilemmas only increase? JAMA 2004 0.89
38 Challenges in diagnosis, treatment and follow-up of patients presenting with central nervous system infections in a resource-limited setting. Mcgill J Med 2006 0.89
39 Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic. J Int AIDS Soc 2009 0.88
40 Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy. J Acquir Immune Defic Syndr 2008 0.88
41 Diagnostic challenges of sexually transmitted infections in resource-limited settings. Future Microbiol 2009 0.85
42 Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci 2007 0.83
43 First report of Actinobaculum schaalii urinary tract infection in North America. Diagn Microbiol Infect Dis 2010 0.82
44 The prevalence and causes of visual loss among HIV-infected individuals in Uganda. J Acquir Immune Defic Syndr 2010 0.82
45 Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS 2002 0.81
46 Disease diagnosis in primary care in Uganda. BMC Fam Pract 2014 0.81
47 A renal aspergilloma--an unusual presentation of aspergillosis in an HIV patient. Afr Health Sci 2005 0.80
48 Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS 2016 0.80
49 Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr 2016 0.80
50 Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study. J Acquir Immune Defic Syndr 2016 0.78
51 Correction: Improving Facility Performance in Infectious Disease Care in Uganda: A Mixed Design Study with Pre/Post and Cluster Randomized Trial Components. PLoS One 2016 0.75
52 Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans. J Acquir Immune Defic Syndr 2014 0.75
53 Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. J Acquir Immune Defic Syndr 2017 0.75
54 Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection. J Acquir Immune Defic Syndr 2016 0.75
55 The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion. AIDS 2017 0.75